Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1326711 | 1.00 | TSHR (0.43) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL2778945 | 1.00 | TSHR (0.43) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL30297359 | 0.86 | TSHR (0.50) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL30297387 | 0.86 | TSHR (0.50) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL3237622 | 0.77 | — | — | |
| SCHEMBL2050716 | 0.77 | TSHR (0.42) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL29547790 | 0.77 | TSHR (0.42) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL7866071 | 0.77 | — | — | |
| SCHEMBL10789722 | 0.77 | TSHR (0.42) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL3237619 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0970069-A4 | TEMPLATE-DIRECTED RING-CLOSING METATHESIS AND RING-OPENING METATHESIS POLYMERIZATION OF FUNCTIONALIZED DIENES | CALIFORNIA INST OF TECHN (US) | 2002-05-02 | — | — | EP | claimed |
| EP-0970069-A1 | TEMPLATE-DIRECTED RING-CLOSING METATHESIS AND RING-OPENING METATHESIS POLYMERIZATION OF FUNCTIONALIZED DIENES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2000-01-12 | — | — | EP | claimed |
| WO-1998030557-A1 | TEMPLATE-DIRECTED RING-CLOSING METATHESIS AND RING-OPENING METATHESIS POLYMERIZATION OF FUNCTIONALIZED DIENES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1998-07-16 | — | — | WO | claimed |
| US-20250042854-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | ECOLE NAT SUPERIEURE DE CHIMIE DE RENNES (FR) | 2025-02-06 | — | — | US | disclosed |
| EP-4433451-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | Ecole Nationale Supérieure de Chimie de Rennes (FR) | 2024-09-25 | — | — | EP | disclosed |
| WO-2023088919-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | ECOLE NATIONALE SUPÉRIEURE DE CHIMIE DE RENNES (FR) | 2023-05-25 | — | — | WO | disclosed |
| EP-1883658-B2 | METHOD FOR PREPARING LOW MOLECULAR WEIGHT POLYMERS | BRIDGESTONE CORP (JP) | 2016-01-27 | — | — | EP | disclosed |
| US-8058351-B2 | Method for preparing low molecular weight polymers | BRIDGESTONE CORPORATION (JP) | 2011-11-15 | — | — | US | disclosed |
| EP-1883658-B1 | METHOD FOR PREPARING LOW MOLECULAR WEIGHT POLYMERS | BRIDGESTONE CORP (JP) | 2011-08-03 | — | — | EP | disclosed |
| CN-100516009-C | Supported ruthenium nanoparticle catalysts for cis-dihydroxylation and oxidative cleavage of alkenes | UNIV HONG KONG (HK) | 2009-07-22 | — | — | CN | disclosed |
| US-20090105423-A1 | Method for preparing low molecular weight polymers | BRIDGESTONE CORPORATION (JP) | 2009-04-23 | — | — | US | disclosed |
| WO-2005082819-A2 | METAL COMPLEXES FOR USE IN OLEFIN METATHESIS AND ATOM GROUP TRANSFER REACTIONS | UNIVERSITEIT GENT (BE) | 2005-09-09 | — | — | WO | disclosed |
| WO-2005035121-A2 | SCHIFF BASE METAL COMPLEXES FOR USE AS CATALYSTS IN ORGANIC SYNTHESIS | UNIVERSITEIT GENT (BE) | 2005-04-21 | — | — | WO | disclosed |
| EP-1468004-A1 | METAL COMPLEXES FOR USE IN METATHESIS | Universiteit Gent (BE) | 2004-10-20 | — | — | EP | disclosed |
| WO-2003062253-A1 | METAL COMPLEXES FOR USE IN METATHESIS | UNIVERSITEIT GENT (BE) | 2003-07-31 | — | — | WO | disclosed |
| EP-0970069-A4 | TEMPLATE-DIRECTED RING-CLOSING METATHESIS AND RING-OPENING METATHESIS POLYMERIZATION OF FUNCTIONALIZED DIENES | CALIFORNIA INST OF TECHN (US) | 2002-05-02 | — | — | EP | disclosed |
| EP-1180108-A2 | IMIDAZOLIDINE-BASED METAL CARBENE METATHESIS CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-02-20 | — | — | EP | disclosed |
| WO-2000071554-A2 | IMIDAZOLIDINE-BASED METAL CARBENE METATHESIS CATALYSTS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2000-11-30 | — | — | WO | disclosed |
| EP-0970069-A1 | TEMPLATE-DIRECTED RING-CLOSING METATHESIS AND RING-OPENING METATHESIS POLYMERIZATION OF FUNCTIONALIZED DIENES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998030557-A1 | TEMPLATE-DIRECTED RING-CLOSING METATHESIS AND RING-OPENING METATHESIS POLYMERIZATION OF FUNCTIONALIZED DIENES | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1998-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250042854-A1 | IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF | SQLE, SYMPK, FDFT1 | TSHR 4508/4885CHRM2 4368/4885CHRM4 4331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.